Valeant Pharmaceuticals International Ruby Engineer Salaries in Wilmington, DE
The average Valeant Pharmaceuticals International Ruby Engineer in Wilmington, DE earns an estimated $86,348 annually, which includes an estimated base salary of $80,257 with a $6,091 bonus. Valeant Pharmaceuticals International's Ruby Engineer compensation is $20,862 less than the US average for a Ruby Engineer. Ruby Engineer salaries at Valeant Pharmaceuticals International in Wilmington, DE can range from $63,500 - $100,000.
In Wilmington, DE, The Engineering Department at Valeant Pharmaceuticals International earns $3,196 more on average than the Business Development Department.
Last updated 2 years ago.
- $80,257
- avg. base
- $6,091
- avg. bonus
Ruby Engineer Salaries at Valeant Pharmaceuticals International
In Wilmington, DE, Ruby Engineers earn $2,352 more than Developers, and $2,397 less than Senior QAs.
Compensation at Valeant Pharmaceuticals International by Department
In Wilmington, DE, The Engineering Department averages $3,196 more than the Business Development Department, and $7,188 less than the Operations Department
Ruby Engineer Compensation by Gender (All Companies)
The average female Ruby Engineer at companies similar size to Valeant Pharmaceuticals International reported making $123,753, while the average male Ruby Engineer at similar sized companies reported making $124,781.
Ruby Engineer Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Ruby Engineer at companies similar size to Valeant Pharmaceuticals International reported making $128,749, while the average African American/Black Ruby Engineer at similar sized companies reported making $102,002.
How Ruby Engineers at Valeant Pharmaceuticals International Rate Their Compensation
The majority of Ruby Engineers at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Ruby Engineers at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
